Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Aquaporins: important but elusive drug targets.
Riluzole enhances glutamate uptake in rat astrocyte cultures.
The analysis of correlation between IL-1B gene expression and genotyping in multiple sclerosis patients.
Cost of disorders of the brain in Spain.
Haplotypes across the human caveolin 1 gene upstream purine complex significantly alter gene expression: Implication in neurodegenerative disorders.
The role of microbiome in central nervous system disorders.
Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme.
Leukocyte infiltration across the blood-spinal cord barrier is modulated by sleep fragmentation in mice with experimental autoimmune encephalomyelitis.
Comparison of a 1.5T standard vs. 3T optimized protocols in multiple sclerosis patients.
Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosis.
Optic Neuritis Probably Induced by Isotretinoin.
160 Surgical outcomes of trigeminal neuralgia in patients with multiple sclerosis.
ICV-transplanted human glial precursor cells are short-lived yet exert immunomodulatory effects in mice with EAE.
Can smoking aggravate my multiple sclerosis symptoms?
Clinical analysis of the etiology of optic neuritis in patients at different ages in china.
Humoral immune response to influenza vaccine in natalizumab-treated MS patients.
TRPM4 cation channel mediates axonal and neuronal degeneration in experimental autoimmune encephalomyelitis and multiple sclerosis.
Role of the Programmed Death-1 (PD-1) pathway in regulation of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
ER Chaperone BiP/GRP78 Is Required for Myelinating Cell Survival and Provides Protection during Experimental Autoimmune Encephalomyelitis.
Rebound of disease activity during pregnancy after withdrawal of fingolimod.
Structure and signalling in the IL-17 receptor family.
Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study.
Yoga for multiple sclerosis: a systematic review and meta-analysis.
Immune cells after prolonged Natalizumab therapy: implications for effectiveness and safety.
Shifting imaging targets in multiple sclerosis: From inflammation to neurodegeneration.

Pages